United States
US 12,702,666 B2
Abuse-resistant pharmaceutical composition for the treatment of opioid dependence
US 12,702,666 B2 is a granted patent from the United States Patent and Trademark Office (USPTO), dated 2026-08-11. Applicant: EDENBRIDGE PHARMACEUTICALS, LLC. Its PDF downloads from this page without an account, up to 5 a day.
- Applicant
- EDENBRIDGE PHARMACEUTICALS, LLC
- Inventors
- Andreas Fischer
- Publication date
- 2026-08-11
- Filing date
- 2023-12-08
- Document type
- B2 Granted patent
- Also written as
- US 12,702,666 B2 · US12702666 · 12702666
Abstract
There is provided pharmaceutical compositions for the treatment of e.g. opioid dependency comprising microparticles of a pharmacologically-effective amount of buprenorphine, or a pharmaceutically-acceptable salt thereof, in associative admixture with particles comprising a weak acid, or particles comprising weakly-acidic buffer forming materials. The composition may further comprise a disintegrant and/or particles of a pharmacologically-effective amount of naloxone, or a pharmaceutically-acceptable salt thereof.…
The opening of the abstract. The full text is in the PDF.
No account needed: 5 free downloads a day (5 left today). Batch downloads and Office Action citations need a free account.
Patent office website: United States Patent and Trademark Office (USPTO)
Look up another patent
Need many patents at once?
Paste a whole list of numbers. DownloadPatent finds the right version of each and packs the PDFs into one ZIP.
Sign up free